NNovo Nordisk Read More Novo Nordisk drug shows no MACE benefit in ZEUS trial | NVO SEC Filing2026-07-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 6-K ________________ REPORT…